Comments on this technology were invited from clinical experts working in the field and relevant patient organisations. The comments received are individual opinions and do not represent NICE's view.

Wound healing in patients with diabetic ulcers is better with weekly applications of a dehydrated human amnion/chorion membrane allograft (EpiFix, MiMedx Group, Mariette, Georgia) compared with either ...

MARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the 15 th anniversary of EPIFIX and AMNIOFIX, the Company’s placental ...

MARIETTA, Ga., Feb.25, 2014 /PRNewswire/ --MiMedx Group, Inc.(NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed ...

MARIETTA, Ga., Sept. 12, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that the Japanese ...

Tissue from donated placenta brings relief to patients with chronic wounds Kelly Winlock, a below-the-knee amputee, spent years trying and failing treatments to heal leg wounds, but only in the past ...

MARIETTA, Ga., Feb.10, 2014 /PRNewswire/ -- MiMedx Group, Inc.(NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed ...

GATWICK, England--(BUSINESS WIRE)--Systagenix (Gatwick, U.K.), announced today that it will launch EPIFIX ® in the United States in March as part of a global distribution agreement reached with MiMedx ...

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced ...

Industry’s Most Studied Placental Allografts Appear in Nearly 100 Clinical and Scientific Publications MARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX” or ...

EpiFix is regulated under the European Union Tissue and Cells Directives (2004/23/EC, 2006/17/EC, 2006/86/EC and 2012/39/EU) and the Human Tissue (Quality and Safety for Human Application) Regulations ...